Financials

  • Market Capitalization 62.1798 B
  • Employee 51 K
  • Founded N/A
  • CEO Steven H. Collis
  • Website www.cencora.com
  • Headquarter Delaware, United States
  • FIGI BBG000MDCQC2
  • Industry Technology
Ricavi totali
Utile netto
Utile base per azione (EPS base)
Debito totale
Liquidità libera
Disponibilità liquide e mezzi equivalenti
Rapporto prezzo/utili
39.26
Rapporto prezzo/fatturato
0.19
Dividendi per azione
2.2
Rendimento da dividendi %
0.7

Cencora Inc

Cencora, Inc., formerly known as AmerisourceBergen, is an American drug wholesale and distribution company and a contract research organization, that was formed by the merger of Bergen Brunswig and AmeriSource in 2001. It was renamed to Cencora in 2023. Cencora is one of the largest pharmaceutical companies in the world and distributes generic pharmaceuticals, over-the-counter healthcare products, as well as home healthcare supplies and equipment.

Notizie